Indivior Pharmaceuticals Ownership | Who Owns Indivior Pharmaceuticals?


OverviewRevenueFinancialsChartTranscripts

Indivior Pharmaceuticals Ownership Summary


Indivior Pharmaceuticals is owned by 61.10% institutional investors, 0.51% insiders, and 38.39% retail investors. Oaktree capital management lp is the largest institutional shareholder, holding 208.42% of INDV shares.

INDV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIndivior Pharmaceuticals61.10%0.51%38.39%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Oaktree capital management lp257.79M208.42%$10.69M
Blackrock funding, inc. /de18.23M14.58%$654.11M
Deerfield management company, l.p. (series c)6.99M5.65%$168.45M
Madison avenue partners, lp6.46M5.23%$155.84M
Fuller & thaler asset management6.37M5.10%$228.61M
Vanguard group5.47M4.38%$196.40M
Two seas capital lp5.11M4.09%$183.32M
Morgan stanley4.38M3.50%$157.07M
Newtyn management4.20M3.40%$101.26M
Divisadero street capital management, lp3.36M2.72%$81.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Newtyn management4.20M12.40%$101.26M
Madison avenue partners, lp6.46M9.30%$155.84M
Alta fundamental advisers409.53K6.62%$14.69M
Mangrove partners2.74M4.88%$66.12M
Two seas capital lp5.11M3.78%$183.32M
Divisadero street capital management, lp3.36M3.54%$81.07M
Krensavage asset management339.53K3.49%$8.19M
Bardin hill management partners lp87.61K2.63%$2.11M
Deerfield management company, l.p. (series c)6.99M2.57%$168.45M
Melqart asset management (uk)616.86K1.98%$14.87M

Top Buyers

HolderShares% AssetsChange
Oaktree capital management lp257.79M0.16%246.78M
Blackrock funding, inc. /de18.23M0.01%9.50M
Divisadero street capital management, lp3.36M3.54%3.23M
Fuller & thaler asset management6.37M0.79%3.20M
Vanguard group5.47M0.00%2.01M

Top Sellers

HolderShares% AssetsChange
Two seas capital lp5.11M3.78%-5.39M
Deerfield management company, l.p. (series c)6.99M2.57%-3.58M
Goldman sachs group3.18M0.01%-3.40M
Scopia capital management lp---1.65M
Madison avenue partners, lp6.46M9.30%-1.46M

New Positions

HolderShares% AssetsChangeValue
Victory capital management806.19K0.01%806.19K$19.44M
Driehaus capital management424.38K0.07%424.38K$10.23M
Russell investments group402.89K0.01%402.89K$9.71M
Woodline partners lp266.00K0.03%266.00K$6.41M
Diadema partners lp254.25K1.57%254.25K$6.13M

Sold Out

HolderChange
Hexagon capital partners-12.00
Eversource wealth advisors-47.00
Bare financial services-66.00
Rothschild investment-140.00
Guardian wealth management-160.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025170-17.87%76,377,598-37.14%610.65%107-26.71%444.76%
Sep 30, 202519960.48%119,522,45811.82%951.28%14174.07%4066.67%
Jun 30, 20251224.27%106,838,01517.06%861.59%8033.33%24-36.84%
Mar 31, 202513-88.79%48,332,235-37.62%391.13%8-87.10%3-88.46%
Dec 31, 20241167.41%77,486,1829.39%582.04%628.77%26-3.70%

Recent Insider Transactions


DateNameRoleActivityValue
Mar 06, 2026Kingsley Stuart A-Buy$29.95K
Mar 09, 2026Ryan Barbara-Buy$1.01K
Jan 05, 2026Ryan Barbara-Buy$27.43K
Jan 05, 2026Humphreys Keith-Buy$27.43K
Jan 05, 2026NINIVAGGI DANIEL A-Buy$27.43K

Insider Transactions Trends


DateBuySell
2028 Q2--
2028 Q1--
2026 Q15-

INDV Ownership FAQ


Who Owns Indivior Pharmaceuticals?

Indivior Pharmaceuticals shareholders are primarily institutional investors at 61.10%, followed by 0.51% insiders and 38.39% retail investors. The average institutional ownership in Indivior Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Indivior Pharmaceuticals exceeds.

Who owns the most shares of Indivior Pharmaceuticals?

Indivior Pharmaceuticals’s largest shareholders are Oaktree capital management lp (257.79M shares, 208.42%), Blackrock funding, inc. /de (18.23M shares, 14.58%), and Deerfield management company, l.p. (series c) (6.99M shares, 5.65%). Together, they hold 228.66% of Indivior Pharmaceuticals’s total shares outstanding.

Does Blackrock own Indivior Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Indivior Pharmaceuticals.

Who is Indivior Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Newtyn management is Indivior Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.40% of its assets in 4.2M Indivior Pharmaceuticals shares, valued at 101.26M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools